Alan Farney to Immunosuppression
This is a "connection" page, showing publications Alan Farney has written about Immunosuppression.
Connection Strength
0.844
-
Farney AC, Doares W, Kaczmorski S, Rogers J, Stratta RJ. Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA. Immunotherapy. 2010 Nov; 2(6):879-88.
Score: 0.359
-
Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009 Sep 27; 88(6):810-9.
Score: 0.333
-
Stratta RJ, Farney AC, Rogers J, Orlando G. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Expert Rev Clin Immunol. 2014 Jan; 10(1):117-32.
Score: 0.112
-
Rogers J, Farney AC, Al-Geizawi S, Iskandar SS, Doares W, Gautreaux MD, Hart L, Kaczmorski S, Reeves-Daniel A, Winfrey S, Ghanta M, Adams PL, Stratta RJ. Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center. Rev Diabet Stud. 2011; 8(1):17-27.
Score: 0.023
-
Moore PS, Farney AC, Hartmann EL, Rogers J, Doares W, Gautreaux MD, Iskandar SS, Hairston G, Adams PL, Stratta RJ. Experience with deceased donor kidney transplantation in 114 patients over age 60. Surgery. 2007 Oct; 142(4):514-23; discussion 523.e1-2.
Score: 0.018